Ethyl 1-(piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylate

Catalog No.: 
ACLBNG940
CAS No.: 
1211517-35-9
Molecular Formula: 
C10H16N4O2
Molecular Weight: 
224.26
Ethyl 1-(piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$469.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 1-(piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylate
IUPAC Nameethyl 1-(piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylate
Molecular FormulaC10H16N4O2
Molecular Weight224.26
SMILESO=C(C1=CN(C2CCNCC2)N=N1)OCC
InChI KeyGIZDRDOYDMROIJ-UHFFFAOYSA-N
Synonym1-Piperidin-4-yl-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester;1H-1,2,3-Triazole-4-carboxylic acid, 1-(4-piperidinyl)-, ethyl ester;Ethyl 1-(piperidin-4-yl)-1H-1,2,3-triazole-4-carboxylate
CAS No.1211517-35-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLBNG940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLBNG940 route product structure diagram
    ACLBNG9401211517-35-9
Inquiry

2. ACLBNG940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLBNG940 route product structure diagram
    ACLBNG9401211517-35-9
Inquiry

3. ACLBNG940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLBNG940 route product structure diagram
    ACLBNG9401211517-35-9
Inquiry

Comments (0)